美国一项最新研究成果显示,目前的早期卵巢癌筛查方法总体上并不能降低患者死亡率,反而容易产生误诊。这项研究是美国犹他大学的科学家进行的,在芝加哥举行的美国临床肿瘤学会年会上公布,并发表在最新一期《美国医学会杂志》(JAMA)网络版上。卵巢癌病情发展较快,但患病早期没有易于辨认的症状,因此发现时往往为时已晚。如果能在早期获得准确诊断,就可及时进行治疗,延长患 A recent study by the United States shows that the current screening methods for early ovarian cancer generally do not reduce the patient’s mortality rate, but are prone to misdiagnosis. The study was conducted by scientists at the University of Utah, USA, at the annual meeting of the American Society of Clinical Oncology in Chicago and in the latest issue of the JAMA online edition. Ovarian cancer develops rapidly but early symptoms are not readily identifiable, so finding it is often too late. If you can get an accurate diagnosis in the early, you can prompt treatment, to extend the suffering